Seminars in Thrombosis and Hemostasis

Article	Citations
COVID-19 and Venous Thromboembolism: A Meta-analysis of Literature Studies	188
SARS-2 Coronavirus–Associated Hemostatic Lung Abnormality in COVID-19: Is It Pulmonary Thrombosis or Pulmonary Embolism?	72
Increased VWF and Decreased ADAMTS-13 in COVID-19: Creating a Milieu for (Micro)Thrombosis	71
Coronavirus Disease 2019 Coagulopathy: Disseminated Intravascular Coagulation and Thrombotic Microangiopathy—Either, Neither, or Both	68
Venous Thromboembolism in Patients Discharged after COVID-19 Hospitalization	64
Different Anticoagulant Regimens, Mortality, and Bleeding in Hospitalized Patients with COVID-19: A Systematic Review and an Updated Meta-Analysis	51
Impaired Breakdown of Bradykinin and Its Metabolites as a Possible Cause for Pulmonary Edema in COVID-19 Infection	42
COVID-19 and Antiphospholipid Antibodies: Time for a Reality Check?	41
Hematology Laboratory Abnormalities in Patients with Coronavirus Disease 2019 (COVID-19)	39
Bleeding and Bleeding Risk in COVID-19	38
Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism	36
Coronavirus Disease 2019: The Role of the Fibrinolytic System from Transmission to Organ Injury and Sequelae	35
Protective Effects of Statins Administration in European and North American Patients Infected with COVID-19: A Meta-Analysis	33
Thrombin Generation and Cirrhosis: State of the Art and Perspectives	33
Thrombin: A Pivotal Player in Hemostasis and Beyond	31
Is Lupus Anticoagulant a Significant Feature of COVID-19? A Critical Appraisal of the Literature	29
Relative Hypercoagulopathy of the SARS-CoV-2 Beta and Delta Variants when Compared to the Less Severe Omicron Variants Is Related to TEG Parameters, the Extent of Fibrin Amyloid Microclots, and the Se	28
Hormonal Contraceptives and the Risk of Venous Thrombosis	26
Presenting Characteristics, Treatment Patterns, and Outcomes among Patients with Venous Thromboembolism during Hospitalization for COVID-19	25
Circulating Heparan Sulfate Proteoglycans as Biomarkers in Health and Disease	25
Mean Platelet Volume Predicts Severe COVID-19 Illness	22
Pulmonary Megakaryocytes in Coronavirus Disease 2019 (COVID-19): Roles in Thrombi and Fibrosis	22
The Role of Fibrin(ogen) in Wound Healing and Infection Control	22
Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease	21
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)—Part I	21

Netting Liver Disease: Neutrophil Extracellular Traps in the Initiation and Exacerbation of Liver Pathology	21
Patients with Congenital Bleeding Disorders Appear to be Less Severely Affected by SARS-CoV-2: Is Inherited Hypocoagulability Overcoming Acquired Hypercoagulability of Coronavirus Disease 2019 (COVID-	21
Thromboelastometry Variables in Neonates with Perinatal Hypoxia	20
Thromboelastography-Guided Management of Anticoagulated COVID-19 Patients to Prevent Hemorrhage	20
Cerebral Venous Thrombosis Developing after COVID-19 Vaccination: VITT, VATT, TTS, and More	19
Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1)	19
Circulating Plasminogen Concentration at Admission in Patients with Coronavirus Disease 2019 (COVID-19)	19
The Role of Red Blood Cells in Hemostasis	19
Endothelial Heparan Sulfate Proteoglycans in Sepsis: The Role of the Glycocalyx	18
Platelet Activation and Thrombosis in COVID-19	18
Coronavirus (COVID-19), Coagulation, and Exercise: Interactions That May Influence Health Outcomes	18
Circulating Levels of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Are Independent Predictors of Coronavirus Disease 2019 Severity: A Prospective, Observational Study	18
Use of Glucocorticoids and Risk of Venous Thromboembolism: A Narrative Review	18
Rotational Thromboelastometry in Neonates Admitted to a Neonatal Intensive Care Unit: A Large Cross-sectional Study	18
Spontaneous Muscle Hematoma in Patients with COVID-19: A Systematic Literature Review with Description of an Additional Case Series	18
Biology of the Heparanase–Heparan Sulfate Axis and Its Role in Disease Pathogenesis	17
A Review of Coagulation Abnormalities of Autoimmune Acquired Factor V Deficiency with a Focus on Japan	17
Iron Oxide Nanoparticles as Imaging and Therapeutic Agents for Atherosclerosis	17
Thrombosis and Hemostasis Issues in Cancer Patients with COVID-19	17
Oral Contraceptives and Venous Thromboembolism: Focus on Testing that May Enable Prediction and Assessment of the Risk	17
Platelet Function in Viral Immunity and SARS-CoV-2 Infection	17
Snake Venoms in Diagnostic Hemostasis and Thrombosis	17
New Insights into the Pathogenesis, Risk Factors, and Treatment of Portal Vein Thrombosis in Patients with Cirrhosis	16
Mutations Accounting for Congenital Fibrinogen Disorders: An Update	16
Perspectives on Platelet Heterogeneity and Host Immune Response in Coronavirus Disease 2019 (COVID-19)	16
Plasma Antithrombin Values Are Significantly Decreased in Coronavirus Disease 2019 (COVID-19) Patients with Severe Illness	16
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Pediatric Venous Thromboembolism Treatment and Thromboprophylaxis: A Systematic Review of the Literature	16
Advances in the Management of Cancer-Associated Thrombosis	16
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19): Part II	15
Confronting COVID-19: Issues in Hemophilia and Congenital Bleeding Disorders	15
Arterial Thrombotic Events in Hospitalized COVID-19 Patients: A Short Review and Meta-Analysis	15
The Impact of SARS-CoV-2 Infection on Blood Coagulation and Fibrinolytic Pathways: A Review of Prothrombotic Changes Caused by COVID-19	15
Incidence of Bleeding and Thrombosis in Patients with Liver Disease	15
New-Onset Atrial Fibrillation in Sepsis: A Narrative Review	15
The More Recent History of Hemophilia Treatment	14
Atypical Spontaneous Hematomas in a Patient with Severe Coronavirus Disease 2019 (COVID-19)	14
Fibrinolysis in Acute and Chronic Cardiovascular Disease	14
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)—Part III	14
Profile of Patients with Isolated Distal Deep Vein Thrombosis versus Proximal Deep Vein Thrombosis or Pulmonary Embolism: RE-COVERY DVT/PE Study	14
Testing for Lupus Anticoagulants	14
Sulodexide versus Control and the Risk of Thrombotic and Hemorrhagic Events: Meta-Analysis of Randomized Trials	13
Fibrinolytic Alterations in Sepsis: Biomarkers and Future Treatment Targets	13
D-dimers—“Normal” Levels versus Elevated Levels Due to a Range of Conditions, Including “D-dimeritis,” Inflammation, Thromboembolism, Disseminated Intravascular Coagulation, and COVID-19	13
Direct Oral Anticoagulants Plasma Levels Measurement: Clinical Usefulness from Trials and Real-World Data	13
What We Know (and Do not Know) Regarding the Pathogenesis of Pulmonary Thrombosis in COVID-19	13
Viscoelastic Tests as Point-of-Care Tests in the Assessment and Management of Bleeding and Thrombosis in Liver Disease	13
Thrombin Generation in Patients with Coronavirus Disease 2019	13
Dosage of Anticoagulants in Obesity: Recommendations Based on a Systematic Review	13
Disseminated Intravascular Coagulation: The Past, Present, and Future Considerations	13
Immune-Mediated Coagulopathy in COVID-19 Infection	13

Contemporary Clinical Use of Aspirin: Mechanisms of Action, Current Concepts, Unresolved Questions, and Future Perspectives	13
Solid Phase Assays for Antiphospholipid Antibodies	12
Evaluating Performance of Contemporary and Historical von Willebrand Factor (VWF) Assays in the Laboratory Identification of von Willebrand Disease (VWD): The Australasian Experience	12
Emerging Roles of Heparan Sulfate Proteoglycans in Viral Pathogenesis	12
The Pathophysiological Role of Platelet-Derived Extracellular Vesicles	11
Laboratory Diagnosis of von Willebrand Disease (VWD): Geographical Perspectives	11
Arterial Thrombosis in Patients with Antiphospholipid Syndrome: A Review and Meta-Analysis	11
Systemic Antiangiogenic Therapies for Bleeding in Hereditary Hemorrhagic Telangiectasia: A Practical, Evidence-Based Guide for Clinicians	11
Single, Dual, and Triple Antithrombotic Therapy in Cancer Patients with Coronary Artery Disease: Searching for Evidence and Personalized Approaches	11
To Anticoagulate or Not to Anticoagulate in COVID-19: Lessons after 2 Years	11
Fibrinolysis in Patients with Liver Disease	11
Pharmacotherapy for Prevention and Management of Thrombosis in COVID-19	11
Gene Therapy for Inherited Bleeding Disorders	11
Anti-Xa Monitoring of Low-Molecular-Weight Heparin during Pregnancy: A Systematic Review	11
Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Insights from Pivotal and Extension Studies	11
Utilization of the Caprini Score for Risk Stratification of the Arthroplasty Patient in the Prevention of Postoperative Venous Thrombosis	11
COVID-19 and Sex-/Gender-Specific Differences: Understanding the Discrimination	11
Hemostasis and Liver Regeneration	11
Current Challenges in the Peripartum Management of Women with von Willebrand Disease	11
Laboratory Testing for Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: A Narrative Review	10
ROTEM Testing for Direct Oral Anticoagulants	10
The Biological Significance of von Willebrand Factor O-Linked Glycosylation	10
Increased Levels of Inflammatory and Endothelial Biomarkers in Blood of Long COVID Patients Point to Thrombotic Endothelialitis	10
Does Chronic Treatment with Oral Anticoagulants Ameliorate the Clinical Course of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Coronavirus Disease 2019 (COVID-19)?	10
Platelet Function and Turnover in Essential Thrombocythemia: A Systematic Review	10
Clinical Performance of Nonvitamin K Antagonist Oral Anticoagulants in Real-World Obese Patients with Atrial Fibrillation	10
Involvement of Inflammation in Venous Thromboembolic Disease: An Update in the Age of COVID-19	10
Why, Whom, and How to Screen for Chronic Thromboembolic Pulmonary Hypertension after Acute Pulmonary Embolism	10
Hyperfibrinolysis in Patients with Solid Malignant Neoplasms: A Systematic Review	10
Platelet Function Testing: Update and Future Directions	10
The Benefits of Heparin Use in COVID-19: Pleiotropic Antiviral Activity beyond Anticoagulant and Anti-Inflammatory Properties	10
Celebrating 50 Years of Seminars in Thrombosis and Hemostasis—Part I	10
Fibrinolysis in Traumatic Brain Injury: Diagnosis, Management, and Clinical Considerations	10
The Clotting Trigger Is an Important Determinant for the Coagulation Pathway In Vivo or In Vitro—Inference from Data Review	10
Cancer-Related Venous Thromboembolism: From Pathogenesis to Risk Assessment	9
2020 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles	9
Mechanisms of Bone Remodeling Disorder in Hemophilia	9
Type 2B von Willebrand Disease in Pregnancy: A Systematic Literature Review	9
Celebrating 50 Years of Seminars in Thrombosis and Hemostasis—Part II	9
Impaired Fibrinolysis in the Antiphospholipid Syndrome	9
Investigating a Signal of Acquired Hemophilia Associated with COVID-19 Vaccination: A Systematic Case Review	9
Cancer-Associated Splanchnic Vein Thrombosis	9
Venous Thromboembolism among Critically Ill Children: A Narrative Review	9
COVID-19 Vaccine-Associated Immune Thrombosis and Thrombocytopenia (VITT): Diagnostic Discrepancies and Global Implications	9
Tranexamic Acid and Its Potential Anti-Inflammatory Effect: A Systematic Review	9
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)—Part IV	9
Type 2A and 2M von Willebrand Disease: Differences in Phenotypic Parameters According to the Affected Domain by Disease-Causing Variants and Assessment of Pathophysiological Mechanisms	9
Post COVID-19 Arterial Thromboembolism: A Clear and Present Danger	9
Oxford-AstraZeneca ChAdOx1 COVID-19 Vaccine Does Not Alter Platelet Aggregation	9
The Art and Science of Building a Computational Model to Understand Hemostasis	9
Altered Fibrinolysis during and after Surgery	8
COVID-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment	8
One Hundred Years of Congenital Fibrinogen Disorders	8
Diagnostic Testing for von Willebrand Disease: Trends and Insights from North American Laboratories over the Last Decade	8
Cerebral Venous Thrombosis	8
Factor VIII and Factor IX Activity Measurements for Hemophilia Diagnosis and Related Treatments	8
Altered Fibrinolysis in Hematological Malignances	8
The Spectrum of Disease Severity in Cirrhosis and Its Implications for Hemostasis	8
Post-Pulmonary Embolism Syndrome and Functional Outcomes after Acute Pulmonary Embolism	8
Fibrinolysis in Venous Thromboembolism	8
Risk of Bleeding during Implant Surgery in Patients Taking Antithrombotics: A Systematic Review	7
Viscoelastic Testing in the Management of Adult Patients on Mechanical Circulatory Support Devices with Focus on Extracorporeal Membrane Oxygenation	7
The Role of Epigenetics in the Regulation of Hemostatic Balance	7
2022 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles	7
Venous Thromboembolism in Pediatric Cancer Patients with Central Venous Catheter—A Systematic Review and Meta-analysis	7
2020 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards	7
Increased Platelet Activation demonstrated by Elevated CD36 and P-Selectin Expression in 1-Year Post-Recovered COVID-19 Patients	7
The History of Extracorporeal Membrane Oxygenation and the Development of Extracorporeal Membrane Oxygenation Anticoagulation	7
Effect of Multiple Freeze–Thaw Cycles on Coagulation Testing	7
Passive Immunity for Coronavirus Disease 2019: A Commentary on Therapeutic Aspects Including Convalescent Plasma	7
50 Years of Pediatric Hemostasis: Knowledge, Diagnosis, and Treatment	7
Hemostatic Biomarkers and Cancer Prognosis: Where Do We Stand?	7
Efficacy and Safety of D-dimer, Weight, and Renal Function-Adjusted Thromboprophylaxis in Patients with Coronavirus Disease 2019 (COVID-19)	7
Rivaroxaban Compared to Placebo for the Treatment of Leg Superficial Vein Thrombosis: A Randomized Trial	7
A Review of Autoimmune Acquired von Willebrand Factor Deficiency in Japan	7
The Growing Impact of Cardiovascular Oncology: Epidemiology and Pathophysiology	7
2021 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles	7
Dysfibrinogenemia—Potential Impact of Genotype on Thrombosis or Bleeding	7
Challenges in the Production of Convalescent Hyperimmune Plasma in the Age of COVID-19	7
Rotational Thromboelastometry Predicts Transfusion Requirements in Total Joint Arthroplasties	7

Heparin: The Journey from Parenteral Agent to Nasal Delivery	7
Risk and Management of Intracerebral Hemorrhage in Patients with Bleeding Disorders	6
MiRNA 126 as a New Predictor Biomarker in Venous Thromboembolism of Persistent Residual Vein Obstruction: A Review of the Literature Plus a Pilot Study	6
Point-of-Care Diagnostic Assays and Novel Preclinical Technologies for Hemostasis and Thrombosis	6
Analysis of College of American Pathologists von Willebrand Factor Proficiency Testing Program	6
Dynamic Hemostasis and Fibrinolysis Assays in Intensive Care COVID-19 Patients and Association with Thrombosis and Bleeding—A Systematic Review and a Cohort Study	6
Causal Associations Between Cardiovascular Risk Factors and Venous Thromboembolism	6
Mechanisms of Thrombosis in Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia	6
Risk Assessment Models for Thrombosis and Anticoagulant-Related Bleeding in Ambulatory Cancer Patients	6
The Central Role of Acute Phase Proteins in Rheumatoid Arthritis: Involvement in Disease Autoimmunity, Inflammatory Responses, and the Heightened Risk of Cardiovascular Disease	6
Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy: Risk Factors and Prevention	6
Efficacy and Safety of Antifibrinolytic Drugs in Pediatric Surgery: A Systematic Review	6
Clot Waveform Analysis for Monitoring Hemostasis	6
Impact of Thrombosis and Bleeding in Patients with Severe COVID-19 versus Other Viral Pneumonias in the Context of Extracorporeal Membrane Oxygenation	6
Anticoagulant Management and Synthesis of Hemostatic Proteins during Machine Preservation of Livers for Transplantation	6
Acquired Thrombotic Thrombocytopenic Purpura: A Rare Coincidence after COVID-19 mRNA Vaccine?	6
Three-Dimensional Human Neural Stem Cell Models to Mimic Heparan Sulfate Proteoglycans and the Neural Niche	6
Protamine—The Journey from DNA to Heparin Neutralization to Gene therapy	6
Effects of Inflammation on Hemostasis in Acutely Ill Patients with Liver Disease	6
Effect of Heparanase and Heparan Sulfate Chains in Hemostasis	6
The Role of Plasminogen Activator Inhibitor Type 1 (PAI-1) in Placenta-Mediated Pregnancy Complications: A Systematic Review	6
The Current Role of Platelet Function Testing in Clinical Practice	6
Blood Markers of Portal Hypertension Are Associated with Blood Loss and Transfusion Requirements during Orthotopic Liver Transplantation	6
Anabolic–Androgenic Steroid Abuse Impairs Fibrin Clot Lysis	6
Right Atrial Thrombosis and Pulmonary Embolism: A Narrative Review	6
Role of Circulating Microparticles in Type 2 Diabetes Mellitus: Implications for Pathological Clotting	6
The Choice between Plasma-Based Common Coagulation Tests and Cell-Based Viscoelastic Tests in Monitoring Hemostatic Competence: Not an either–or Proposition	6
Reversal Agents for the Direct Factor Xa Inhibitors: Biochemical Mechanisms of Current and Newly Emerging Therapies	5
2023 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles	5
Genomic Analysis for the Detection of Bleeding and Thrombotic Disorders	5
Is Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein a Potential Basis for Autoimmune Responses in Vaccinated and Naturally Infected Patients?	5
Catheter-Directed Thrombolysis in a Patient with Severe COVID-19 Pneumonia on Extracorporeal Membrane Oxygenation	5
Sustained High D-Dimer in Outpatients Who Have Recovered from Mild to Moderate Coronavirus Disease 2019 (COVID-19)	5
Heparan Sulfate Proteoglycans in Diabetes	5
Celebrating 50 Years of Seminars in Thrombosis and Hemostasis—Part III	5
From the Discovery of ADAMTS13 to Current Understanding of Its Role in Health and Disease	5
Fifty Years of Fibrinogen Structure and Function	5
Pulmonary Embolism and Chronic Obstructive Pulmonary Disease	5
Physicians' Opinions on Anticoagulant Therapy in Patients with a Limited Life Expectancy	5
Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies: Current State of the Art	5
Interaction between Antiphospholipid Antibodies and Protein C Anticoagulant Pathway: A Narrative Review	5
Acquired Factor V Inhibitor after Coronavirus Disease 2019 (COVID-19)	5
The Journey Through the Pathogenesis and Treatment of Venous Thromboembolism in Inflammatory Bowel Diseases: A Narrative Review	5
Relevance of Heparan Sulfate and Heparanase to Severity of COVID-19 in the Elderly	5
Toward 50 Years of Seminars in Thrombosis and Hemostasis	5
Neurocoagulation from a Mechanistic Point of View in the Central Nervous System	5
Thrombotic Thrombocytopenic Purpura: From 1972 to 2022 and Beyond	5
The Utility of NATEM Assay in Predicting Bleeding Risk in Critically Ill Neonates	5
The Applicability of Thromboelastography in Acute Ischemic Stroke: A Literature Review	5
Resonant Acoustic Rheometry to Measure Coagulation Kinetics in Hemophilia A and Healthy Plasma: A Novel Viscoelastic Method	5
The Post–Venous Thromboembolism Functional Status Scale: From Call to Action to Application in Research, Extension to COVID-19 Patients, and Its Use in Clinical Practice	5
Fibrinolysis Shutdown and Hypofibrinolysis Are Not Synonymous Terms: The Clinical Significance of Differentiating Low Fibrinolytic States	5
Thromboelastography-Guided Therapy Enhances Patient Blood Management in Cirrhotic Patients: A Meta-analysis Based on Randomized Controlled Trials	5
Use of Direct Oral Anticoagulants in People Living with HIV: A Single-Center Experience	5
New-Onset Atrial Fibrillation and Adverse In-Hospital Outcome in Patients with Acute Pulmonary Embolism	5
Tranexamic Acid Treatment for Trauma Victims	5
Sex-Related Differences in Platelet Aggregation: A Literature Review Supplemented with Local Data from a Group of Generally Healthy Individuals	5
Pulmonary Embolism in Patients with COVID-19: Comparison between Different Care Settings	5
Research Trends in Anticoagulation Therapy over the Last 25 Years	4
Evolution of Antiphospholipid Syndrome	4
Low-Molecular-Weight Heparin Resistance and Its Viscoelastic Assessment in Critically Ill COVID-19 Patients	4
Does COVID-19 Provide a Clue for Thrombosis in ITP?	4
Tissue Plasminogen Activator in Central Nervous System Physiology and Pathology: From Synaptic Plasticity to Alzheimer's Disease	4
Shortcomings in Design and Analysis of Clinical Studies on Bleeding and Thrombosis in Patients with Cirrhosis	4
From Ink Pens to Computers: A Personal Look Back at Landmark Changes during 5 Decades as a Clinical Laboratory Scientist in U.S. Hemostasis Laboratories	4
“True” Antiphospholipid Syndrome in COVID-19: Contribution of the Follow-up of Antiphospholipid Autoantibodies	4
Evolution of Hemostasis Testing: A Personal Reflection Covering over 40 Years of History*	4
Planning Pregnancy and Birth in Women with Inherited Bleeding Disorders	4
The Case for Therapeutic-Intensity Anticoagulation in Patients with COVID-19-Associated Moderate Illness	4
Upper Extremity Deep Vein Thrombosis: Current Knowledge and Future Directions	4
Colchicine as a Modulator of Platelet Function: A Systematic Review	4
Hereditary Angioedema: The Clinical Picture of Excessive Contact Activation	4
New STH (2020) Impact Factor, Most Highly Cited Papers, and Other Journal Metrics	4
The Most Highly Cited Publications from Seminars in Thrombosis and Hemostasis: A Data Analysis 50 Years in the Making	4
Clinical Studies with Anticoagulants that Have Changed Clinical Practice	4
Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Final Results from Extension Studies	4
Strength of Anticoagulation in Moderate to Severe COVID-19 Illness: In Medio Stat Virtus?	4
Hemostasis in the Pregnant Woman, the Placenta, the Fetus, and the Newborn Infant	4
Von Willebrand Factor Multimer Analysis and Classification: A Comprehensive Review and Updates	3
Hemostatic and Nonhemostatic Effects of Heparan Sulfate Proteoglycans	3
Assessment of Hemostatic Profile in Neonates with Intrauterine Growth Restriction: A Systematic Review of Literature	3
How Do Laboratories Perform von Willebrand Disease Diagnostics and Classification of von Willebrand Disease Patients? Results from External Quality Data and an International Survey	3
Antiphospholipid Syndrome in Patients with Venous Thromboembolism	3
Platelet Behavior Contributes to Neuropathologies: A Focus on Alzheimer's and Parkinson's Disease	3
Hypercoagulability and Thrombosis Risk in Prostate Cancer: The Role of Thromboelastography	3
Early Resolution of Heyde's Syndrome following Transcatheter Aortic Valve Replacement	3
Factor XII Structure–Function Relationships	3
Doctor, Do I Have Lupus? Time to Reconsider the Lupus Anticoagulant Terminology	3
Pathogen Reduction Technologies and Their Impact on Metabolic and Functional Properties of Treated Platelet Concentrates: A Systematic Review	3
The Role of Thromboelastography during the Management of Postpartum Hemorrhage: Background, Evidence, and Practical Application	3
Proposal for a Simple Algorithmic Approach to Manage Drug–Drug Interactions of Oral Anticoagulants with Nirmatrelvir/Ritonavir in COVID-19 Outpatients	3
A Perspective on How Fibrinaloid Microclots and Platelet Pathology May be Applied in Clinical Investigations	3
Heterogeneity in Bleeding Tendency and Arthropathy Development in Individuals with Hemophilia	3
A Historical Perspective on the Reversal of Anticoagulants	3
What Role Does Microthrombosis Play in Long COVID?	3